Icotinib in a lung adenocarcinoma patient with acquired EGFR 19del/C797S mutation-mediated resistance to osimertinib: a case report
Article in Anti-Cancer Drugs (July 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Anti-Cancer Drugs (July 2024)
Article in Reactions Weekly (October 2022)